Simultaneous determination of ketamine, tramadol, methadone, and their metabolites in urine by gas chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 32, Issue 3, 2008, Pages 253-259

  Cheng, Pai Sheng ^a   Lee, Choung Huei ^a   Liu, Chiareiy ^a   Chien, Chun Sheng ^a  

^a Executive Yuan   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5 METHYL 3,3 DIPHENYLPYRROLINE; 2 ETHYLIDENE 1,5 DIMETHYL 3,3 DIPHENYLPYRROLIDINE; DRUG METABOLITE; KETAMINE; METHADONE; TRAMADOL; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; METHADONE TREATMENT; RELIABILITY; SOLID PHASE EXTRACTION;

EID: 41649104084     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.3.253     Document Type: Article

References (24)

1. C. Liu, J.-H. Li, W.-I. Tsay, and J. Hsu. Drug use and profile of individuals arrested on drug-related charges in Taiwan. J. Food Drug Anal. 13: 101-106 (2005).
2. P.F. White, W.L. Way, and A.J. Trevor. Ketamine - its pharmacology and therapeutic uses. Anesthesiology 56: 119-136 (1982).
3. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 5th ed. Chemical Toxicology Institute, Foster City, CA, 2000, pp 456-458, 523-527, 845-846.
4. A.C. Moffat, M.D. Osselton, and B.Widdop. Clarke's Analysis of Drugs and Poisons, Vol. 2, 3rd ed. Pharmaceutical Press, London, U.K., 2004, p 1232.
5. H.R. Lin and A.C. Lua. Detection of acid-labile conjugates of ketamine and its metabolites in urine samples collected from pub participants. J. Anal. Toxicol. 28: 181-186 (2004).
6. H.R. Lin and A.C. Lua. Simultaneous determination of amphetamines and ketamines in urine by gas chromatography-mass spectrometry. Rapid Commun. Mass Spectrom. 20: 1724-1730 (2006).
7. M.-L. Olmos-Carmona and M. Hernández-Carrasquilla. Gas chromatographic-mass spectrometric analysis of veterinary tranquillizers in urine: evaluation of method performance. J. Chromatogr. B 734: 113-120 (1999).
8. M.-K. Huang, C. Liu, J.-H. Li, and S.-D. Huang. Quantitative detection of ketamine, norketamine, and dehydronorketamine in urine using chemical derivatization followed by gas chromatography-mass spectrometry. J. Chromatogr. B 820: 165-173 (2005).
9. P.-S. Cheng, C.-Y. Fu, C.-H. Lee, C. Liu, and C.-S. Chien. GC-MS quantification of ketamine, norketamine, and dehydronorketamine in urine specimens and comparative study using ELISA as the preliminary test methodology. J. Chromatogr. B 852: 443-449 (2007).
10. F. Sporkert and F. Pragst. Use of headspace solid-phase microextraction (HS-SPME) in hair analysis for organic compounds. Forensic Sci. Int. 107: 129-148 (2000).
11. U. Staerk and W.R. Külpmann. High-temperature solid-phase microextraction procedure for the detection of drugs by gas chromatography-mass spectrometry. J. Chromatogr. B 745: 399-411 (2000).
12. 1-N-ethyltramadol as an internal standard for the quantitative determination of tramadol in human plasma by gas chromatography-mass spectrometry. J. Chromatogr. B 804: 369-374 (2004).
13. G.I. Kang and F.S. Abbott. Analysis of methadone and metabolites in biological fluids with gas chromatography-mass spectrometry. J. Chromatogr. 231: 311-319 (1982).
14. M.E. Alburges, W. Huang, R.L. Foltz, and D.E. Moody. Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS. J. Anal. Toxicol. 20: 362-368 (1996).
15. A.M. Bermejo, C. Remuiñán, P. Fernándes, and M.J. Tabernero. GC/MS determination of methadone in urine and plasma from patients under detoxification treatment. Anal. Lett. 31: 2645-2661 (1998).
16. C. Moore, F. Guzaldo, M.J. Hussain, and D. Lewis. Determination of methadone in urine using ion trap GC-MS in positive ion chemical ionization mode. Forensic Sci. Int. 119: 155-160 (2001).
17. F.R. Galloway and N.F. Bellet. Methadone conversion to EDDP during GC-MS analysis of urine samples. J. Anal. Toxicol. 23: 615-619 (1999).
18. H. He, C. Sun, X.-R. Wang, C. Pham-Huy, N. Chikhi-Chorfi, H. Galons, M. Thevenin, J.-R. Claude, and J.-M. Warnet. Solid-phase extraction of methadone enantiomers and benzodiazepines in biological fluids by two polymeric cartridges for liquid chromatographic analysis. J. Chromatogr. B 814: 385-391 (2005).
19. K.L. Preston, D.H. Epstein, D. Davoudzadeh, and M.A. Huestis. Methadone and metabolite urine concentrations in patients maintained on methadone. J. Anal. Toxicol. 27: 332-341 (2003).
20. N. Chikhi-Chorfi, C. Pham-Huy, H. Galons, N. Manuel, W. Lowenstein, J.-M. Warnet, and J.-R. Claude. Rapid determination of methadone and its major metabolite in biological fluids by gas-liquid chromatography with thermionic detection for maintenance treatment of opiate addicts. J. Chromatogr. B 718: 278-284 (1998).
21. H.R. Sullivan and S.L. Due. Urinary metabolites of d,l-methadone in maintenance subjects. J. Med. Chem. 16: 909-913 (1973).
22. J.L. Plummer, G.K. Gourlay, D.A. Cherry, and M.J. Cousins. Estimation of methadone clearance: application in the management of cancer pain. Pain 33: 313-322 (1988).
23. C.E. Inturrisi, R.K. Portenoy, M.B. Max, W.A. Colburn, and K.M. Foley. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin. Pharmacol. Ther. 47: 565-577 (1990).
24. Y. Oda and E.D. Kharasch. Metabolism of methadone and levoalpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation. J. Pharmacol. Exp. Ther. 298: 1021-1032 (2001).